Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics

Investment will double capacity to produce active pharmaceutical ingredients used in therapeutics for a broad range of diseases SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong [...]

Quantum-Si Begins Commercial Shipments of the Platinum™ Protein Sequencing System and Provides Business Updates at the 41st Annual J.P. Morgan Healthcare Conference

Company Announces Commercial Shipments of Protein Sequencing System, Reveals New Partnerships, and Reaffirms Commitment to Financial Discipline Launched in December 2022, Platinum is the First Commercially Available Next-Generation Single-Molecule Protein Sequencing System Looking to Unlock the Proteome One Amino Acid at a Time GUILFORD, Conn. --  Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein [...]

Quantum-Si and Aviva Systems Biology Partner to Co-Develop Sample Preparation Kits for Protein Sequencing

Protein Enrichment Kits to Enable Deep Interrogation of Proteoforms through Protein Sequencing GUILFORD, Conn. -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it entered into a partnership with Aviva Systems Biology, a leading provider of antibody, protein, and immunoassay reagent products with an extensive portfolio of over [...]

PacBio and the University of Tokyo Announce Bioinformatics Applications Collaboration

MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of highly accurate sequencing solutions, today announced a collaboration with the University of Tokyo, Graduate School of Medicine to study the use of long-read sequencing and novel bioinformatics methods in the hopes of better understanding the genetic causes of certain rare diseases in individuals and cohorts within the Japanese population. [...]

Avantor® and Catalent Enter into Multi-Year Supply and Services Agreement

RADNOR, Pa. and SOMERSET, N.J. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced that it has entered into a multi-year supply and services agreement with Catalent, Inc. (NYSE: CTLT), the leader in enabling the development [...]

Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research Collaboration

SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a research collaboration with Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) to discover antibodies against multiple targets of interest to develop curative therapies for [...]

Astrea Bioseparations acquires Delta Precision Ltd, a leading manufacturer of chromatography columns for biomanufacturing

Cambridge, UK: Astrea Bioseparations (“Astrea Bio”), a leading provider of high-quality bioseparation and purification technologies, announced today the acquisition of Delta Precision Ltd. (“Delta Precision”), a premier manufacturer of advanced chromatography columns for the biotechnology and pharmaceutical industries. This strategic acquisition, which follows a long-standing relationship of almost a decade, will allow Astrea Bio to expand [...]

Sampling Human Appoints Bob Englert as Chief Operating Officer

The company’s advisory board also expands to include Peter Kuhn, Ph.D., Todd Peterson, Ph.D., and Daniel Lysak, M.D. SAN FRANCISCO -- Sampling Human, Inc., a life science tools company developing single cell technologies, today announced the appointment of Bob Englert as chief operating officer. In this role, Englert will lead the company’s operations, including manufacturing [...]

QIAGEN completes acquisition of Verogen, strengthening leadership in Human ID / Forensics with NGS technologies

Verogen a proven leader in equipping forensic science laboratories and criminal investigators to use next-generation sequencing (NGS) to gain deeper insights Addition of Verogen strengthens QIAGEN leadership in fast-growing field of Human ID / forensics anchored by sample collection and preparation, genetic testing analysis and workflow automation Deal builds on partnership launched in 2021 to distribute [...]

Quanterix Expands Laboratory Developed Test Menu With Launch Of Neurofilament Light Chain Test

New CLIA blood test expands access to important “brain health” biomarker to advance research and clinical care BILLERICA, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced the validation of a Laboratory Developed Test (LDT) to quantitatively measure neurofilament light chain (NfL) in serum [...]

Access IBO on Knowledge Center